Minzasolmin, CAS [[1802518-92-8]]

Produktübersicht

• Artikelname: Minzasolmin, CAS [[1802518-92-8]]
• Artikelnummer: MCE-HY-145580
• Hersteller Artikelnummer: HY-145580
• Alternativnummer: MCE-HY-145580-50MG,MCE-HY-145580-25MG,MCE-HY-145580-10MG,MCE-HY-145580-1MG,MCE-HY-145580-100MG,MCE-HY-145580-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: UCB0599, (R)-NPT200-11

Produktbeschreibung

Minzasolmin (UCB0599, (R)-NPT200-11) is an orally active, blood-brain-permeable alpha-synuclein (alpha-Syn) inhibitor that selectively binds to alpha-Syn misfolded intermediates (such as oligomers) and inhibits aggregation and fibril formation by regulating their conformational stability. Minzasolmin can reduce the generation of pathological oligomers and block neurotoxic signaling, thereby reducing the abnormal accumulation of alpha-Syn in the brain. Minzasolmin significantly improved motor deficits, reduced neuroinflammatory markers, and alpha-Syn-related pathological deposition in transgenic mouse models[1][2].

Produkteigenschaften

• Molekulargewicht: 425.59
• Reinheit: 98.60
• CAS Nummer: [1802518-92-8]
• Formel: C23H31N5OS
• Target-Kategorie: alpha-synuclein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound